Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson’s disease by suppressing the activation of the AKT and NF-κB signaling pathways.

Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson’s disease by suppressing the activation of the AKT and NF-κB signaling pathways.
Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways. Int Immunopharmacol. 2019 Jul 24;75:105739 Authors: Li Y, Zeng Y, Meng T, Gao X, Huang B, He D, Ran X, Du J, Zhang Y, Fu S, Hu G Abstract Neuroinflammation, characterized by the activation of microglia, is ... read more
Source: PubMedPublished on 2019-07-28